Subscribe To

Price Alert Latest News Economic Calendar News

MED / Is MEDIFAST (MED) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Read More

Demo Live Account See Partner Details

Content Topics

Medifast

MED

Great

Value

Stock

Right

Now

Posted: Jun 15 2022, 10:46

Author Name: Zacks Investment Research

MED News

By Zacks Investment Research
November 2, 2023

Medifast (MED) Queues for Q3 Earnings: What Awaits the Stock?

Medifast's (MED) third-quarter results are likely to reflect concerns surrounding customer acquisition amid a challenging landscape. However, a focus

By Zacks Investment Research
September 11, 2023

Medifast (MED) Gains on OPTAVIA Lifestyle Solution Strength

Medifast's (MED) OPTAVIA program is a robust and adaptable solution focused on health and wellness. This holistic approach positions it for sustained

By Zacks Investment Research
September 6, 2023

Why Is Medifast (MED) Down 7.4% Since Last Earnings Report?

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

By Zacks Investment Research
August 8, 2023

Medifast's (MED) Q2 Earnings Top Estimates, Sales Decline Y/Y

Medifast's (MED) second-quarter 2023 results reflect lower sales and earnings on reduced Coach productivity and cost inflation.

By Zacks Investment Research
August 7, 2023

Medifast (MED) Q2 Earnings and Revenues Surpass Estimates

Medifast (MED) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $1.44 per share. This compares to earnings

By Seeking Alpha
August 4, 2023

Medifast: Take Advantage Of Pessimism Over Weight Loss Drugs

Medifast has seen a significant decline in its stock price and market cap in the past 2 years, reflecting investors' pessimism towards the company. Th

By Seeking Alpha
July 21, 2023

In The Murky MLM Space, Medifast Might Actually Hold Some Promise

Medifast, a health and wellness company, has seen its stock price decline by 76% since 2021, despite its Optavia platform helping over 2 million custo

By Seeking Alpha
June 14, 2023

Medifast: A Revamp Is Necessary, An Embrace Of GLP-1s Can Help

I view Medifast's traditional business model at increasing risk from the growing popularity of GLP-1-based drugs. Recent M&A activity within the indus

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.